Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06XXJ
|
|||
| Drug Name |
PMID25468267-Compound-54
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
EPITHERAPEUTICS APS
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H21N3O3
|
|||
| Canonical SMILES |
CCCCN(C)C(=O)CNCC1=NC=CC(=C1)C(=O)O
|
|||
| InChI |
1S/C14H21N3O3/c1-3-4-7-17(2)13(18)10-15-9-12-8-11(14(19)20)5-6-16-12/h5-6,8,15H,3-4,7,9-10H2,1-2H3,(H,19,20)
|
|||
| InChIKey |
ZASDPPHIPJCPAA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lysine-specific demethylase 4 (KDM4) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Lysine-specific demethylase 4 (KDM4) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.